Multisensory integration is an important skill for the developing brain because it helps shape how effectively we make sense of our surroundings, a new study reports.
A new study reports on bow certain brain cells compute the length of sounds and are able to detect shorter noises.
A new study reveals how fast spiking interneurons improve the efficiency of learning a new skill.
Researchers use a new technique to image the process of neurotransmission.
Researchers have discovered a possible new treatment for Alzheimer's disease after noticing the way in which insulin signaling works in the brains and pancreas of diabetic patients.
Researchers have identified a mechanism that could help explain how ketamine helps relieve symptoms of depression.
Using optogenetics to inhibit the JNK protein prevented synapses from shrinking in response to stress.
Researchers explore the mechanisms behind ketamine's effectiveness at treating depression. The study reports the long lasting effects of ketamine may be due to G proteins timing in moving back to lipid rafts.
A new study funded by the NIMH suggests GLYX-13, a molecular cousin to ketamine, induces similar antidepressant results without the negative side effects of the well known street drug.
By inhibiting NMDA receptors, ketamine increases noise to gamma frequencies in one layer of the thalamic nucleus and one lay of the somatosensory cortex. Findings suggest psychosis may be triggered by an increase in background noise impairing thalamocortical neurons which may be caused by a malfunction in NMDA receptors affecting the balance of inhibition and excitation in the brain.
A new study clarifies the mechanism behind how ketamine works as an antidepressant. Researchers say there is evidence to suggest ketamine binds to NMDA receptors, instead of opioid receptors. Reducing the belief that ketamine is an opioid may make patients with depression more open to using the treatment.
Researchers report ketamine's antidepressive effects require activation of opioid receptors in the brain. The study highlights the interaction between depression, pain and opioid addiction.
